Clearside Biomedical, Inc. (CLSD)
NASDAQ: CLSD · IEX Real-Time Price · USD
1.130
-0.040 (-3.42%)
Jul 22, 2024, 10:25 AM EDT - Market open
Clearside Biomedical Employees
Clearside Biomedical had 30 employees as of December 31, 2023. The number of employees decreased by 6 or -16.67% compared to the previous year.
Employees
30
Change (1Y)
-6
Growth (1Y)
-16.67%
Revenue / Employee
$281,733
Profits / Employee
-$1,165,600
Market Cap
86.63M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Alpha Teknova | 211 |
CASI Pharmaceuticals | 176 |
Hyperfine | 131 |
AlloVir | 112 |
HilleVax | 90 |
Verastem | 73 |
BeyondSpring | 36 |
Benitec Biopharma | 18 |
CLSD News
- 11 days ago - Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory Board - GlobeNewsWire
- 25 days ago - Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery - GlobeNewsWire
- 26 days ago - Why Is Clearside Biomedical Stock Gaining Today? - Benzinga
- 5 weeks ago - Clearside Biomedical's Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting - GlobeNewsWire
- 2 months ago - Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA® - GlobeNewsWire
- 2 months ago - Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference - GlobeNewsWire
- 2 months ago - Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024 - GlobeNewsWire